TLV · CBI.TA
Clal Biotechnology Industries Ltd.
₪0.23+₪0.00 (+1.32%)
Clal Biotechnology Industries Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.11% below the high.
Loading market information…
TLV · ALMD.TA · ILA
Stock price, earnings
Quote as of Oct 29, 2026, 03:24 PM UTC. Cached market data; not a live quote.
One-year closing-price history · ILA. Historical prices are not a forecast.
Allmed Solutions Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.69% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Allmed Solutions Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Caesarea, Israel, Allium Medical Solutions Ltd. specializes in the creation, manufacturing, and global distribution of advanced, long-term medical stents. These innovative devices are fully covered, designed for expansion, and are retrievable, serving to alleviate various obstructions within the urinary and gastrointestinal (GI) tracts. Their product portfolio encompasses a range of specialized stents, including those for ureteric, bulbar, triangular and round prostatic, and biliary applications.
Latest available per-share figures in ILS. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:46 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
₪0.23+₪0.00 (+1.32%)
Clal Biotechnology Industries Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.11% below the high.
₪3.13+₪0.15 (+5.18%)
BioLight Life Sciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.9% below the high.
₪1.21-₪0.00 (-0.08%)
Merchavia Holdings and Investments Ltd.’s quoted price sits in the lower half of its reported 52-week range, 63.19% below the high.
₪1.59-₪0.04 (-2.27%)
Identi Healthcare Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.96% below the high.
₪0.22-₪0.02 (-7.5%)
Elbit Medical Technologies Ltd’s quoted price sits in the lower half of its reported 52-week range, 26.0% below the high.
₪0.02+₪0.00 (+7.14%)
XTL Biopharmaceuticals Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.91% below the high.
₪1.13-₪0.04 (-3.25%)
Evogene Ltd.’s quoted price sits in the lower half of its reported 52-week range, 73.59% below the high.
₪66.65+₪6.74 (+11.25%)
Bio-View Ltd’s quoted price sits in the lower half of its reported 52-week range, 80.04% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.